Page 6 - Genetic Therapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetic therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetic Therapies Today - Breaking & Trending Today

Manager of billion pound biotech fund exits JPM

Manager of billion pound biotech fund exits JPM
citywire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citywire.co.uk Daily Mail and Mail on Sunday newspapers.

Aijaz Hussein , Yazann Romahi , Berkan Sesen , Genetic Therapies , ஐஜஸ் ஹுசைன் , ஜெநெடிக் சிகிச்சைகள் ,

Manager steps down from recently soft-closed JPM thematic fund

Manager steps down from recently soft-closed JPM thematic fund
citywireselector.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citywireselector.com Daily Mail and Mail on Sunday newspapers.

Aijaz Hussein , Yazann Romahi , Berkan Sesen , Genetic Therapies , Citywire Selector , ஐஜஸ் ஹுசைன் , ஜெநெடிக் சிகிச்சைகள் ,

Vertex Pharmaceuticals Inc (VRTX) Q4 2020 Earnings Call Transcript


Senior Vice President of Investor Relations
[Technical Issues] relations for Vertex. Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex s CEO and President; Stuart Arbuckle, Chief Commercial Officer; and Charlie Wagner, Chief Financial Officer; Dr. David Altshuler, Chief Scientific Officer; and Dr. Bastiano Sanna, Chief of Cell and Genetic Therapies will join the Q&A portion of the call following the prepared remarks. We recommend that you access the webcast slides on our website as you listen to this call. This conference call is being recorded and a replay will be available on our website.
We will make forward-looking statements on this call that are subject to the risks and uncertainties discussed in detail in today s press release and our filings with the Securities and Exchange Commission. These statements, including, without limitation, those regarding Vertex s marketed CF medicines, our pipeline and Vertex s future financial performa ....

United States , United Kingdom , San Diego , Cory Kasimov , Charlesf Wagner , David Altshuler , Charlie Wagner , Reshma Kewalramani , Bastiano Sanna , Salveen Richter Goldman Sachs , Stuarta Arbuckle , Michael Yee Jefferies , Michael Yee , Phil Nadeau Cowen , Stuart Arbuckle , Phil Nadeau , Salveen Richter , Geoff Meacham , Exchange Commission , Vertex Pharmaceuticals Inc , American Society Of Hematology Annual Meeting , Goldman Sachs , Geoff Meacham Bank , Company Analyst , Vice President , Chief Commercial Officer ,